HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Einar K Rofstad Selected Research

diethylenetriamine

2/2014DCE-MRI of the hypoxic fraction, radioresponsiveness, and metastatic propensity of cervical carcinoma xenografts.
4/2013Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
4/2013Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: a preclinical study of cervical carcinoma and melanoma xenografts.
11/2012Preclinical evaluation of Gd-DTPA and gadomelitol as contrast agents in DCE-MRI of cervical carcinoma interstitial fluid pressure.
10/2012Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI.
5/2012Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
2/2012Dynamic contrast-enhanced-MRI of tumor hypoxia.
9/2011Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Einar K Rofstad Research Topics

Disease

86Neoplasms (Cancer)
10/2021 - 03/2002
32Hypoxia (Hypoxemia)
01/2021 - 02/2002
29Melanoma (Melanoma, Malignant)
01/2020 - 03/2002
16Carcinoma (Carcinomatosis)
01/2021 - 11/2009
14Neoplasm Metastasis (Metastasis)
01/2020 - 03/2002
8Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2019 - 02/2010
6Lymphatic Metastasis
04/2018 - 03/2002
4Hypertension (High Blood Pressure)
02/2014 - 02/2010
3Neoplasm Micrometastasis
01/2020 - 07/2003
3Adenocarcinoma
01/2019 - 01/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 10/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 10/2015
2Necrosis
05/2009 - 06/2008
2Neuroblastoma
03/2005 - 05/2002
2Brain Neoplasms (Brain Tumor)
01/2004 - 03/2002
1Meningeal Neoplasms
12/2015
1Rupture
05/2009
1Body Weight (Weight, Body)
11/2008
1Hyperthermia
07/2006

Drug/Important Bio-Agent (IBA)

30pimonidazoleIBA
01/2021 - 02/2002
21Gadolinium DTPA (Magnevist)FDA Link
10/2014 - 08/2004
15Biomarkers (Surrogate Marker)IBA
04/2020 - 11/2010
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 05/2002
10Oxygen (Dioxygen)IBA
01/2021 - 02/2004
10GadoliniumIBA
02/2014 - 04/2009
8Sunitinib (Sutent)FDA Link
01/2021 - 09/2012
8PENTAIBA
02/2014 - 09/2011
8diethylenetriamineIBA
02/2014 - 09/2011
8Acetic Acid (Vinegar)FDA LinkGeneric
02/2014 - 09/2011
7Dextrans (Dextran)FDA Link
06/2017 - 07/2008
6Interleukin-8 (Interleukin 8)IBA
01/2020 - 03/2005
6tetramethylrhodamine isothiocyanateIBA
03/2015 - 07/2008
5CollagenIBA
10/2021 - 01/2016
5Contrast MediaIBA
04/2013 - 04/2006
5A-factor (Streptomyces)IBA
11/2009 - 03/2005
4Bevacizumab (Avastin)FDA Link
01/2020 - 11/2015
3Cisplatin (Platino)FDA LinkGeneric
07/2020 - 10/2014
3Therapeutic UsesIBA
01/2020 - 05/2009
3gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
11/2017 - 11/2015
3properdistatinIBA
06/2017 - 03/2015
3Thrombospondin 1IBA
11/2016 - 07/2003
3Urokinase Plasminogen Activator ReceptorsIBA
03/2005 - 03/2002
2AngiopoietinsIBA
04/2018 - 10/2017
2Proteins (Proteins, Gene)FDA Link
10/2017 - 04/2017
2Angiogenesis InhibitorsIBA
06/2017 - 09/2012
2Vascular Endothelial Growth Factor CIBA
04/2017 - 07/2014
2Peptides (Polypeptides)IBA
11/2016 - 03/2015
2Matrix Metalloproteinases (MMPs)IBA
12/2015 - 07/2006
2Lactic Acid (Lactate)FDA LinkGeneric
10/2015 - 01/2013
2contrast agent P792IBA
11/2012 - 10/2011
2Neutralizing AntibodiesIBA
11/2010 - 03/2002
2BoronIBA
01/2004 - 03/2002
1Antihypertensive Agents (Antihypertensives)IBA
01/2020
1Immune Checkpoint InhibitorsIBA
01/2020
1Losartan (Cozaar)FDA LinkGeneric
01/2020
1Protein Isoforms (Isoforms)IBA
04/2018
1IntegrinsIBA
04/2018
1Neuropilin-2IBA
10/2017
1Eosine Yellowish-(YS) (Eosin)IBA
10/2017
1Hematoxylin (Haematoxylon)IBA
10/2017
1Transforming Growth Factor beta (TGF-beta)IBA
07/2017
1Insulin-Like PeptidesIBA
07/2017
1angiogeninIBA
07/2017
1EnzymesIBA
04/2017
1ImmunosorbentsIBA
04/2017
1platelet-derived growth factor AIBA
04/2017
1ProperdinIBA
11/2016
1Ferritins (Ferritin)IBA
08/2016
1Green Fluorescent ProteinsIBA
06/2016
1Carbonic Anhydrase IXIBA
10/2015
1DNA (Deoxyribonucleic Acid)IBA
05/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1Pentetic Acid (DTPA)FDA LinkGeneric
01/2013
1Biological ProductsIBA
09/2011
1N 30IBA
09/2011
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2010
1Thymidine PhosphorylaseIBA
10/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2010
1Bleomycin (Blenoxane)FDA LinkGeneric
05/2009
11-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2009
1AcidsIBA
04/2009
1ParaffinIBA
11/2008
1N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA
07/2006
1Cathepsin LIBA
07/2006
1Matrix Metalloproteinase InhibitorsIBA
07/2006
1Cysteine Proteinase InhibitorsIBA
07/2006
1Peptide Hydrolases (Proteases)FDA Link
07/2006
1E 64IBA
07/2006
1Cathepsin BIBA
07/2006

Therapy/Procedure

13Radiotherapy
10/2018 - 07/2003
8Catheters
08/2019 - 05/2011
4Chemoradiotherapy
07/2020 - 10/2014
4Therapeutics
01/2020 - 02/2008
2Drug Therapy (Chemotherapy)
10/2018 - 07/2006
2Photochemotherapy (Photodynamic Therapy)
05/2009 - 07/2006
1Duration of Therapy
01/2020
1Transplantation
04/2018
1Intra-Arterial Injections
12/2015
1Intradermal Injections
05/2012
1Electrodes (Electrode)
11/2005